![John Markels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Markels
Direktor/Vorstandsmitglied bei
SANGAMO THERAPEUTICS, INC.
Vermögen: 5 211 $ am 31.07.2026
Profil
John H.
Markels is an Independent Director at Sangamo Therapeutics, Inc. since 2020.
He is a Director at Arcturus Therapeutics, Inc. and Arcturus Therapeutics Ltd. He has been an Independent Director at Arcturus Therapeutics Holdings, Inc. since 2022.
He is an Independent Director at Vaxcyte, Inc. starting in 2026.
Formerly, Dr. Markels was President-Global Vaccines at Merck & Co., Inc. from 2019 to 2022.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Delaware.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 71.384 ( 0,02 % ) | 5 211 $ | 31.07.2026 | |
| 05.06.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von John Markels
| Unternehmen | Position | Beginn |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.02.2020 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Direktor/Vorstandsmitglied | 08.12.2022 |
| VAXCYTE, INC. | Direktor/Vorstandsmitglied | 16.07.2026 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direktor/Vorstandsmitglied | - |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von John Markels
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01.03.2022 |
Ausbildung von John Markels
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
